By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Eiger Biopharma 

Palo Alto  California    U.S.A.
Phone: n/a Fax: n/a


Start Up

Company News
Eiger Biopharma Announces First Patient Dosed In Phase 2 Study Of Pegylated Interferon Lambda In Hepatitis D Virus (HDV) Infection 10/19/2016 6:52:36 AM
Eiger Biopharma Announces Orphan Designation Of Exendin 9-39 For Treatment Of Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS) From EMA 10/17/2016 8:28:03 AM
Eiger Biopharma Announces Abstracts And Presentations Of LOWR HDV Program At The American Association for Study of Liver Diseases Meeting 10/13/2016 9:00:20 AM
Eiger Biopharma Announces Completion Of Dosing In Phase 2 LOWR HDV - 4 Study At Hannover Medical School 9/7/2016 8:30:13 AM
Eiger Biopharma To Present At The BioCentury NewsMakers In The Biotech Industry Conference On September 9th 9/6/2016 1:16:31 PM
Eiger Biopharma To Present At The 5th Annual Liolios Gateway Conference On September 7, 2016 9/1/2016 8:20:53 AM
Eiger Biopharma Announces Proposed Public Offering Of Common Stock 8/18/2016 8:11:20 AM
Eiger Biopharma Reports Second Quarter 2016 Financial Results 8/11/2016 9:39:50 AM
Eiger Biopharma To Present At The 2016 Wedbush PacGrow Healthcare Conference On August 17th 8/8/2016 11:06:08 AM
Eiger Biopharma Announces Partnership With The Hepatitis B Foundation 7/28/2016 6:41:11 AM